Background: The distension of the bladder during intracavitary brachytherapy (ICBT) affects the applicator position and in turn the dose to tumour and normal structures.
INTRODUCTION
Image-guided intracavitary application plays a major role in the success of outcome for cervical cancer and has improved 5-year control rates to the tune of 88%. [1] The practice of brachytherapy has shifted from X-ray-based point prescription to computed tomography (CT)-based volume prescription. The two important critical structures are rectum and bladder with a reported moderate to severe chronic proctitis and cystitis of 2%-6%, [2] respectively. As bladder and rectum are distensible organs, their volume will indirectly affect the position of the applicators and in turn the target coverage and dose to rectum and bladder. While rectal distension cannot be monitored and controlled, bladder volume can be kept relatively constant during different fractions and hence could be objectively studied. Various studies have tried to address this and studied keeping bladder empty or filling the bladder with different volumes ranging from 20 ml to an amount till the patient becomes uncomfortable. [3] [4] [5] [6] We at the department are using cobalt-based high dose rate (HDR) intracavitary application prescribing high risk volume to a dose of 6.5 GyX 4 Fr with 2 fractions per day given at 6-h interval over 2 days.
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SUBJECTS AND METHODS
Histologically proven 40 cervical cancer patients treated with concurrent chemoradiation between December 2015 and July 2017 in the department of radiation oncology at a tertiary care hospital were the individuals of this prospective study. Institutional ethical committee approval was obtained, and a sample size of 40 was decided in consultation with biostatistician to get 80% power and 95% confidence level with effect size of 0.67. All patients underwent a clinical examination, biopsy, complete blood counts, renal function tests, liver function tests, contrast-enhanced CT scan of abdomen, and pelvis. They were treated with standard 3DCRT technique to a dose of 4500 cGy in 25 fractions over 5 weeks along with 3-5 weekly cycles of cisplatin chemotherapy.
Around 10 days later, they underwent intracavitary brachytherapy (ICBT) under spinal anesthesia. After Foley's catheter insertion, intracavitary application was done and CT simulation was done taking three mm cuts. First scan was performed from lower border of obturator foramen to 2 cm above the tip of the applicator with bladder empty. Second scan was performed at the same anatomic level with bladder distended with 100 ml of normal saline and contrast mixture with ratio of 9:1. CT scan images were transferred to HDR plus planning system.
The high risk clinical target volume (HRCTV) and organs at risk (OARs) were contoured first in primary image series with distended bladder as well as in the second series with bladder empty. The entire cervix with the uterus sparing topmost three sections, presumed extension along vagina and parametrium was contoured as HRCTV. Bladder was contoured cranially from dome of bladder up to bladder neck caudally. Rectum was contoured cranially from rectosigmoid junction up to anal canal caudally. Sigmoid colon was contoured caudally from rectosigmoid junction up to descending colon cranially. Bowel bag was contoured cranially 2 cm proximal to the tip of central tandem to up to visible part caudally. Intermediate risk clinical target volume (IRCTV) was created with margin of 1 cm from HRCTV. Then, IRCTV was trimmed from the OARs.
The plan was generated and evaluated and treatment was executed after optimization. The generated plan in the primary image series was transferred to secondary image series. Dosimetric comparison was done between two image series which included target coverage, dose to bladder (D2cc, D5cc, Dmax, and D50), dose to rectum (D2cc), dose to sigmoid colon (D2cc), and dose to bowel (D2cc). The reference point for calculating the shift was kept at the flange level on the tandem. The distance between the reference point and the closest point on the posterior wall of the bladder was measured in both image series to calculate in X, Y, and Z to calculate the positional variation of the applicators [ Figure 1 ]. All patients, treated with full bladder, to a dose of 6.5 GyX 4 fractions were given on two consecutive days with 6 h gap between two fractions. From the time the patient was shifted after CT simulation, till delivery of last fraction, the patient was kept on the same stretcher without shifting.
Data were analyzed using statistical software, SPSS Inc. Release 2009 PASW statistics for Windows version 18.0, Chicago, Illinois, USA. P < 0.05 was considered for statistical significance. Paired t-test and Wilcoxon signed-rank test were used for determining statistical parameters and statistical significance of difference between parameters between two sets of patients' data.
RESULTS
Forty patients of cervical cancer underwent single application and multiple fractions of 6.5 Gy/fr for 4 fractions given over 2 days with a minimum gap of 6 h between two fractions. The age of the group ranged from 43 to 65 years. Stagewise distribution was 1 (2.5%), 30 (75%), 7 (17.5%), and 2 (5%) patients in stage I B, II B, III B, and IV A, respectively.
Dosimetric parameters
The target coverage ranged from 67.4%-97.5% to 68.3%-97.6%; the median coverage was 84.15% and 84.85% with full bladder and empty bladder, respectively, with P value of 0.003. Dosimetric details of bladder are shown in Graph 1: maximum dose to bladder was 6 Gy in distended bladder and 7.25 Gy with empty bladder with P = value 0.000. The median bladder dose in distended bladder versus empty bladder was1.57 Gy (±0.51) versus 2 Gy (±0.46) (P = 0.000), D5cc-3.94 Gy (±0.55) versus 4.17 Gy (±0.94) (P = 0.103), and D2cc-4.5 Gy (±0.53) versus 5 Gy (±1.36) (P = 0.01), respectively. Dose to rectum, sigmoid colon, and bowel are shown in Graph 2. Rectum D2cc was 3.76 Gy (±0.51) versus 4.07 Gy (±0.36) (P = 0.000), Sigmoid D2cc-2.18 Gy (±0.95) versus 2.43 Gy (±1.23) (P = 0.005), and Bowel D2cc-2.81 Gy (±1.0) versus 3.43 Gy (±1.19) (P = 0.000), respectively, in distended bladder versus empty bladder.
Positional variation -bladder distension versus empty bladder
The mean distance of the posterior wall of the bladder from reference point was 0.042 cm versus 0.079 cm (P = 0.391) in the X-axis, −0.618 cm versus −0.630 cm (P = 0.603) in Z-axis, and 0.19 cm versus 0.26 cm (P = 0.009) in the Y-axis between two status of the bladder [Graph 3].
DISCUSSION
Our prospective study was designed to assess bladder distension effect on various dosimetric parameters for OARs (bladder, rectum, sigmoid, and bowel), target coverage, and in addition, any positional variation in applicator compared to empty bladder condition. Similar studies were done previously by various authors. Patra et al. had three arms of up to 40cc, 41-80 cc, and more than 80cc, [3] while Cengiz et al. used maximum tolerated volume which was an average of 250 ml. [4] Pilepich et al. compared 50 ml versus maximum comfortable to the patient which was around 280 ml; [5] they did a CT simulation and used anterolateral views for planning. The plan was superimposed on the CT image, doses to the base and lateral wall of the bladder were calculated, and shift at the ovoid and two inches above the ovoid level were measured. Mahantshetty et al. studied empty versus 50 ml versus 100 ml and 7 Gy was prescribed to point A after CT simulation. [6] The main difference between these and our work was that they prescribed to point A while ours was a volume-based prescription.
In the study by Pilepich et al., [5] there was no difference in target coverage in bladder empty versus bladder filled conditions while our study showed a significantly improved coverage in empty bladder (P = 0.003). Cengiz et al. [4] prescribed to point A and the reference volume of ICRU38 was used to check target coverage on CT scan, and it was observed that the target was inadequately covered in both series. All other authors have used X-ray-based planning, and hence, target coverage could not be compared.
Mean dose to bladder reduces with distension of the bladder. This was uniformly observed by all the above authors and is in compliance with our findings. Radiation exposure to a large part of the bladder was diminished significantly by more than 50% in around 88% patients to the anterior wall of the bladder and by 25%-79% in around 53% patients to the lateral wall of the bladder by maintaining a residual vesicalvolume 200-300 ml with contrast material. [4] Our study showed 21.5% reduction which might be explained by greater bladder distension of 255 ml versus 100 ml in our study. Another difference was that in our study, the measurement was volume based while in their study, it was measured for the base and lateral walls. As the bladder distends, major portion is shifted away from the source and hence mean dose is expected to reduce and at the same time base is closer to the source and hence smaller volumes receive higher dose.
Doses to smaller volumes such as 0.1cc, 2cc, and 5cc increased with full bladder. As the bladder size increases, the base of the bladder is closer to the applicators compared to empty bladder. However, Patra et al. [3] and Cengiz et al. [4] found that there was no difference between two series as far as smaller volumes of bladder were considered. Maximum dose to bladder was higher with full bladder (993 vs. 925cGy) as per Cengiz et.al., [4] in our study it was the converse 7.25 Gy versus 6 Gy with empty and full bladder respectively. The planning parameters and optimization could be the reason as ours was a volume-based treatment while they had done point A-based planning which was extrapolated onto the planning CT scan. Doses to the small volume are also important as this volume is reported as minimal volume required for telangiectasia and ulceration/fistula. [2] As the bladder distends, bowel is pushed away from the applicators, and hence, dose received is lower compared to empty bladder. All dose values of small intestine decreased significantly with bladder filling. The median maximal doses to the small intestine were significantly higher with an empty bladder (493 vs. 284 cGy), [4] and this is observed uniformly by all authors.
The rectal doses were also altered by bladder distension. The maximum dose was significantly reduced in the distended bladder (481 vs. 628cGy). [4] Probable reason might be the distended bladder might have caused posterior displacement of applicators which might have increased the max dose, dose to 1 cc and 2 cc of rectum. In contrast, Harmon et al. [7] observed that although there was significant reduction of all dose volume parameters of bladder, bowel, and sigmoid, there was no difference in rectal dose between empty versus 200 ml bladder filling; similar observation were made by Sun et al. [8] with 220 ml of bladder instillation. Dose to sigmoid was higher in empty bladder compared to full bladder. This is probably just an observation since the contribution is mainly from the uterine tandem, avoiding the dwell position at the tip reduces dose to sigmoid and is less likely to be related to the bladder volume.
Due to distension of bladder, the applicators are expected to shift in the posterior direction. Positional variation was studied in X, Y, and Z axis in bladder distended versus bladder empty condition. Shift in Y-axis was significant 0.19 cm (bladder distension) versus 0.26 cm (bladder empty) (P = 0.009) in our study. Similar observation in anteroposterior direction of 1 mm and 3 mm in the lateral was observed in a study done by Koushik et al. [9] The rotational variation at flange level was 3° in transverse plane and 4° in the sagittal plane. In this X-ray-based low-dose-rate intracavitary treatment duration of about 25 h, the X-ray done at the end of treatment was compared with the planning X-ray, and it is to be noted that the bladder was kept empty throughout. Pilepich et al. [5] observed in their work on ICBT that the shift was 1-10 mm at the ovoid level and 15 mm at 2 inches above the ovoid level.
There are many works done to assess the dose to OARs. To the best of our knowledge, this is the only study that assessed all three, dose volume parameters to OARs, target coverage as well as the shift in applicators in a CT/volume HDR ICBT. All the doses were well within the recommended limits as per Groupe Européen de Curiethérapie and the European SocieTy for Radiotherapy & Oncology (GEC ESTRO) in both empty and filled bladder series. As the results have improved with image-guided brachytherapy, patients are expected to live longer, and hence, it becomes very important to keep as low as possible. Also reducing the dose to smaller volumes receiving higher doses is also important to further reduce grade two and above chronic side effects. One of the limitations of our study is that this is purely a dosimetric study, and clinical correlation was not a part of the objective, and we would like to study this in the future.
CONCLUSION
The applicator system in ICBT is subject to changes in the volume of bladder which in turn affects significantly the dose received by the tumor as well as normal tissues. Filled bladder pushes the applicator down. The distended bladder makes smaller volume of the bladder receive higher dose and larger volumes a lower dose. However, this does not translate into a higher rectal dose. It remains to be seen whether this difference is of any clinical significance to the late radiation effects on bladder and rectum.
